Baxter International adopts executive severance plan; shareholders approve incentive plan
Baxter's board approved an Executive Severance and Change in Control Plan effective May 4, 2026, which sets tiered severance for executives including the Interim CFO. At the May 5, 2026 annual meeting, shareholders approved a 20,000,000-share increase to the incentive plan, a charter amendment changing board size limits, and all nine director nominees.
Key points
- Severance Plan effective May 4, 2026; non-CIC terminations pay 1.5x salary plus target bonus, and CIC terminations pay 2.0x.
- Hider offer letter amended to raise the lump-sum medical coverage payment for non-CIC terminations from 18 months to 24 months.
- Shareholders approved adding 20,000,000 shares to the Second Amended and Restated 2021 Incentive Plan, with 362,762,566 votes for and 77,492,842 against.
- Charter amendment sets the minimum number of directors at seven with no stated maximum; bylaws set a range of seven to twelve directors.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.